PON1 and metabolic syndrome: Grzegorzewska et al. (2021) further reinforced the cardiovascular protective role of PON1, reporting an association between lower PON1 activity and a higher prevalence of atherogenic dyslipidemia and cardiovascular mortality in hemodialysis patients [28].